SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (1205)3/3/1998 9:20:00 AM
From: The Gambler  Read Replies (2) of 2173
 
Tony, thanks for your advice. Don't worry, I'm not emotionally attached or heavily invested in.

I only have small stake and have previous experienced with similar situation. I have a rather sizeable amount of shares in ALTN which about a year ago had funding dilemma. After a major partner dropped the cooperation, the stock drifted down all the way to 2-1/4, but has since recovered. Reason given by the collaborative partner to ALTN was similar to reason given by JNJ to AMLN, but in fact there was a toxicity problem in the result of findings.

ALTN had proven it's critics wrong, and is on the way of filing with FDA, I believe next year.
I take this incident with AMLN as a slow down. Sorry if I take anyone's time to much.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext